Local immunotherapy in the neoadjuvant treatment of cancer: optimizing efficacy while limiting toxicity?

Strikwerda MA, Hoeijmakers LL, Veenstra SPGR, Van Den Eertwegh AJM, Labots M, Blank CU, Mom CH, De Gruijl TD

Open source

DOI
10.1136/jitc-2025-014324
Published
2026 May 13
Container
Journal for immunotherapy of cancer
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1136/jitc-2025-014324,
  title = {Local immunotherapy in the neoadjuvant treatment of cancer: optimizing efficacy while limiting toxicity?},
  author = {Strikwerda MA and Hoeijmakers LL and Veenstra SPGR and Van Den Eertwegh AJM and Labots M and Blank CU and Mom CH and De Gruijl TD},
  year = {2026},
  journal = {Journal for immunotherapy of cancer},
  doi = {10.1136/jitc-2025-014324},
  url = {https://doi.org/10.1136/jitc-2025-014324}
}

RIS

TY  - JOUR
TI  - Local immunotherapy in the neoadjuvant treatment of cancer: optimizing efficacy while limiting toxicity?
AU  - Strikwerda MA
AU  - Hoeijmakers LL
AU  - Veenstra SPGR
AU  - Van Den Eertwegh AJM
AU  - Labots M
AU  - Blank CU
AU  - Mom CH
AU  - De Gruijl TD
PY  - 2026
JO  - Journal for immunotherapy of cancer
DO  - 10.1136/jitc-2025-014324
UR  - https://doi.org/10.1136/jitc-2025-014324
ER  - 

APA

MA, S., LL, H., SPGR, V., AJM, V. D. E., M, L., CU, B., CH, M., & TD, D. G. (2026). Local immunotherapy in the neoadjuvant treatment of cancer: optimizing efficacy while limiting toxicity?. Journal for immunotherapy of cancer. https://doi.org/10.1136/jitc-2025-014324

Source records